GENETICS  BACK

Flavia de Santis - 05 MARCH 2024

CRISPR Knockouts vs Knockins

Not so long ago, the addition, removal and modiBcation of parts of the genome were only possible in science-Bction
movies. In the past years, the CRISPR/Cas9 technology has made these processes a concrete possibility, revolutionizing
the Beld of genome engineering and offering scientists the possibility to perform an endless number of genetic
modiBcations, including knockouts and knockins. In this post, we will go over the available knockout and knockin
techniques and how they differ so that you can choose the one that is most appropriate for your experiment.

Differences between knockouts and knockins

As mentioned before, the CRISPR/Cas9 technology represents a powerful tool for both procedures: the system acts as
molecular scissors and is able to recognize and “cut” speciBc regions of the DNA to initiate the process of genome
editing. Upon DNA damage, the organism puts in place different DNA-repair mechanisms that scientists can take
advantage of to produce the intended modiBcation.

The term “knockout” (KO) has been borrowed from combat sports, where it is employed to deBne a situation in which
one of the two opponents is unable to pursue the match as a consequence of an attack suffered. Similarly, in genetics, the
term knockout refers to cases in which, as a consequence of the disruption of its sequence, a gene becomes unable to
play its biological role (e.g. to produce a protein responsible for a speciBc function).

“Knockin” (KI) approaches are employed to realize modiBcations meant to add an exogenous sequence in the targeted
locus.

Knockouts: techniques
To generate a knockout, researchers exploit the non-homologous-end joining (NHEJ) pathway, the most common
endogenous DNA repair mechanism. Once the CRISPR/Cas9 recognizes and breaks the target DNA region, this repair
system tries to restore the original sequence by putting back together the two extremities of the damaged DNA. This
mechanism is error-prone and could lead to the insertion or deletion of a few bases (INDELS) that modify the original
sequence. When these INDELS are not multiple of 3 can cause frameshift (a change in the reading frame) and
introduction of premature STOP codons.

If the target region is located at the beginning of a gene, the generation of INDELS leads to the complete inactivation of
the gene impeding the production of the encoded protein. If the target region is placed later, INDELS results in the
generation of a modiBed or truncated protein that is likely unable to perform its biological function.

CRISPR mechanism to induce loss-of-function gene mutation. The Cas9-mediated induction of double-strand
break (DSB) activates endogenous mechanisms of DNA repair, aiming to Bx the genomic damage produced at the
locus of interest. These error-prone mechanisms can induce different outcomes in the target locus.

Knockouts: applications
A knockout model allows us to understand the biological function of a protein by observing what happens if the
protein is missing. In this sense, the zebraQsh represents an ideal model organism to study the effect of a gene
knockout as its small size and transparency offer scientists the possibility to visualize, in real-time, many different
biological processes.

An additional application of the knockout approach is the generation of disease models. Many human pathologies are
caused by genetic mutations, natural knockouts in which speciBc proteins are missing or not-functioning. A disease
model recapitulates the pathological phenotypes associated with the disease and allows scientists to investigate its
causes or to test putative therapies. Also in this case the zebraBsh extends a helping hand to scientists as disease
modeling in this small organism makes it possible to perform high-throughput screenings to test therapeutic
compounds or gene therapies.

CRISPR/Cas9 Gene Knockout

Contact us to discuss your custom model

Knockins: techniques
Different technologies have been developed to allow the targeted insertion of a genetic sequence. All approaches rely on
the provision of a “donor DNA” (containing the exogenous sequence of interest) together with the CRISPR/Cas9
machinery. Two repair mechanisms can be employed to obtain a KI: the already mentioned NHEJ and the homology-
directed repair (HDR).

In the Brst case, the KI is successful if, instead of joining the two extremities of the broken DNA, the NHEJ combines one
extremity of the broken DNA with one side of the donor DNA.

In the second option, the HDR employs the donor DNA as a template to synthesize a new DNA chain. To promote HDR,
the donor has to contain two “homology arms” (HAs) aanking the exogenous sequence to be inserted into the genome.
The HAs need to be identical to the sequences at the sides of the CRISPR/Cas9 genomic target.

Knockins: applications
Knockin approaches can be employed to introduce short or long DNA sequences serving different experimental
purposes. Indeed, knockin strategies can be employed to generate single base changes (point mutations) causing small
modiBcations in a protein sequence.

Compared to a knockout, in which the protein encoded by the target gene is missing or nonfunctional, this approach is a
better choice to model human diseases in which a point mutation induces an adverse gain of function (e.g. the
mutated protein acquires a toxic function). Knockin can be also employed to insert sequences allowing “conditional
knockout”, a technique in which the target sequence is selectively removed in speciBc tissues or at a speciBc time-point.
This approach allows scientists to focus on the role of a protein in a particular cell type or in a precise developmental
stage. The knockin of longer DNA sequences makes it possible to label proteins of interest with a tag or a auorescent
reporter, providing researchers with a reliable manner to visualize them. Similarly, selected tissues or cell clusters can be
labeled by a auorescent reporter to generate reporter lines.

Unlike knockouts, whose efQciency has been shown to be very high, knockin approaches are more challenging and
require a complex optimization process. Indeed, despite many efforts to increase the success rate of this approach, there
is still a poor consensus on which is the optimal strategy to generate the desired knockin. In this context, ZeClinics is
strongly committed to establishing the best procedure to modify ad hoc the genome of our favorite model organism: our
team is working tirelessly to improve and optimize existing technologies and to develop novel approaches to establish the
most efBcient pipeline for zebraBsh genome modiBcation.
 By Flavia de Santis

Flavia obtained her master’s degree in medical biotechnologies from the University of Bari (Italy), then she
pursued her scienti>c education at the Institut Curie (Paris), where she obtained a Ph.D. in neuronews.
During her doctorate, she focused her research on vertebrate neural circuit development and, in parallel,
worked on the implementation of innovative CRISPR/Cas9-based genome engineering approaches. Since
she joined ZeClinics as a senior scientist, she has been coordinating a wide range of genetics services while
working in the development of cutting-edge technologies to achieve a more ef>cient generation of
zebra>sh models for #therapeutic target validation.

Facebook
Twitter
LinkedIn
Email
Wh
CRISPR/Cas9 Disease modeling Disease models Gene-editing genetic bases genetic models genetic screening

knock-in knock-out preclinical research target validation

RELATED POSTS

Common Errors in ZebraAsh Genetic Model Generation

Transgenic Animals in Biomedical Research and Drug Discovery

PREVIOUS POST NEXT POST

Prime editing, a step beyond CRISPR Fast Gene Target Validation & Drug Screening All In One

Categories
CNS (4)
Drug discovery (17)
Genetics (15)
Metabolics (2)
Ophthalmology (3)
Toxicology (7)
ZebraBsh model organism (9)

Tags

3Rs acute toxicity alternative models animal experimentation animals in scientiBc research artiBcial intelligence

Chemical toxicity CRISPR/Cas9 data science deep learning developmental neurotoxicity

developmental toxicology Disease modeling Disease models ecotoxicology endocrine disruption

environmental chemicals environmental toxicology epilepsy Gene-editing genetic bases genetic models

genetic screening High Throughput Screening knock-in knock-out knowledge graph machine learning

NAMs neurology phenotypic screening preclinical research predictability predictive toxicology R&D

REACH regulatory compliance target validation teratogenicity tol2 transgenic Translatability

validity ZebraBsh zebraBsh embryos

Recent Posts
Recent Posts
AI’s Role in Transforming Drug Discovery: A New Frontier
Data Science in the Drug Discovery Industry
Knowledge Graphs for Drug Discovery: Transforming Target IdentiBcation and Biomedical Data Integration
Common Errors in ZebraBsh Genetic Model Generation
CRISPR/Cas9 vs. Tol2 Techniques for ZebraBsh Genomic Manipulation

 BACK

Privacy policy Terms of Use Cookies Manage Cookies

© 2024 ZeClinics

Designed by Auupa

 